Concord Biotech

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE338H01029
  • NSEID: CONCORDBIO
  • BSEID: 543960
INR
1,367.60
-7.4 (-0.54%)
BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 77.7 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
257.49
326.08
277.77
247.06
203.99
429.88
244.22
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
257.49
326.08
277.77
247.06
203.99
429.88
244.22
Raw Material Cost
69.85
70.54
66.59
57.30
59.91
80.27
60.96
Purchase of Finished goods
11.29
15.67
20.44
13.65
12.85
10.32
12.19
(Increase) / Decrease In Stocks
-26.85
-0.40
-21.30
-21.93
-27.65
37.91
-20.75
Employee Cost
43.64
47.77
46.78
44.46
37.90
38.97
34.64
Power Cost
34.72
29.76
28.44
28.53
29.48
29.34
26.44
Manufacturing Expenses
0.00
0.00
0.00
-0.01
-0.01
-0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
42.46
44.21
37.83
36.57
30.11
42.66
32.79
Total Expenditure (Excl Depreciation)
175.11
207.55
178.78
158.57
142.59
239.46
146.27
Operating Profit (PBDIT) excl Other Income
82.38
118.53
98.99
88.49
61.40
190.42
97.95
Other Income
12.83
15.35
9.98
13.35
13.68
9.38
14.73
Operating Profit (PBDIT)
95.21
133.88
108.97
101.84
75.08
199.80
112.68
Interest
0.04
0.08
0.08
0.06
0.06
0.10
0.10
Exceptional Items
0.00
0.00
-3.28
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
95.17
133.80
105.61
101.78
75.02
199.70
112.58
Depreciation
18.10
19.54
18.75
18.39
17.78
14.62
13.26
Profit Before Tax
78.34
114.08
86.16
85.68
58.73
183.54
101.15
Tax
20.65
25.61
22.51
22.62
14.67
43.16
25.23
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
56.42
88.65
64.34
60.77
42.57
141.94
74.09
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
56.42
88.65
64.34
60.77
42.57
141.94
74.09
Share in Profit of Associates
1.28
-0.18
-0.70
2.29
1.49
-1.55
1.83
Minority Interest
-0.83
-0.32
-0.84
-0.52
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
58.53
88.79
64.48
63.58
44.06
140.39
75.92
Equity Capital
10.46
10.46
10.46
10.46
10.46
10.46
10.46
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
5.6
8.49
6.16
6.08
4.21
13.42
7.26
Diluted Earnings per share
5.52
8.46
6.08
6.03
4.21
13.42
7.26
Operating Profit Margin (Excl OI)
31.99%
36.35%
35.64%
35.82%
30.1%
44.3%
40.11%
Gross Profit Margin
36.96%
41.03%
38.02%
41.2%
36.78%
46.45%
46.1%
PAT Margin
22.41%
27.13%
22.91%
25.52%
21.6%
32.66%
31.09%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is -21.03% vs 17.39% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is -34.08% vs 37.70% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is -30.50% vs 19.74% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is -50.00% vs 0.00% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

Compare Quarterly Results Of Concord Biotech With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
257.49
2,290.00
-2,032.51
-88.76%
Other Operating Income
0.00
0.00
0.00
Total Operating income
257.49
2,290.00
-2,032.51
-88.76%
Raw Material Cost
69.85
642.80
-572.95
-89.13%
Purchase of Finished goods
11.29
84.50
-73.21
-86.64%
(Increase) / Decrease In Stocks
-26.85
-14.00
-12.85
-91.79%
Employee Cost
43.64
766.90
-723.26
-94.31%
Power Cost
34.72
0.00
34.72
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
42.46
470.50
-428.04
-90.98%
Total Expenditure (Excl Depreciation)
175.11
1,950.70
-1,775.59
-91.02%
Operating Profit (PBDIT) excl Other Income
82.38
339.30
-256.92
-75.72%
Other Income
12.83
23.70
-10.87
-45.86%
Operating Profit (PBDIT)
95.21
363.00
-267.79
-73.77%
Interest
0.04
56.50
-56.46
-99.93%
Exceptional Items
0.00
-13.70
13.70
100.00%
Gross Profit (PBDT)
95.17
292.80
-197.63
-67.50%
Depreciation
18.10
116.80
-98.70
-84.50%
Profit Before Tax
78.34
176.00
-97.66
-55.49%
Tax
20.65
56.70
-36.05
-63.58%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
56.42
119.30
-62.88
-52.71%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
56.42
119.30
-62.88
-52.71%
Share in Profit of Associates
1.28
0.00
1.28
Minority Interest
-0.83
-0.10
-0.73
-730.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
58.53
119.40
-60.87
-50.98%
Equity Capital
10.46
15.80
-5.34
-33.80%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
5.60
7.56
-1.96
-25.93%
Diluted Earnings per share
5.52
7.52
-2.00
-26.60%
Operating Profit Margin (Excl OI)
31.99%
14.93%
0.00
17.06%
Gross Profit Margin
36.96%
12.89%
0.00
24.07%
PAT Margin
22.41%
5.25%
0.00
17.16%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 257.49 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -21.03% vs 17.39% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 26.23% vs -5.47% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 58.53 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -34.08% vs 37.70% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 32.84% vs -26.06% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 82.38 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -30.50% vs 19.74% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 34.17% vs -24.46% in Jun 2025

Quarterly - Interest
Interest 0.04 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -50.00% vs 0.00% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -33.33% vs -75.00% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.99%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025